Financial Advocates Investment Management Cuts Stock Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Financial Advocates Investment Management reduced its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 5.3% during the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 1,666 shares of the medical equipment provider’s stock after selling 94 shares during the period. Financial Advocates Investment Management’s holdings in Intuitive Surgical were worth $870,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also recently modified their holdings of ISRG. Berbice Capital Management LLC acquired a new position in shares of Intuitive Surgical during the fourth quarter worth $26,000. Godsey & Gibb Inc. grew its stake in Intuitive Surgical by 140.0% during the 3rd quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider’s stock worth $29,000 after buying an additional 35 shares during the last quarter. MidAtlantic Capital Management Inc. purchased a new stake in Intuitive Surgical in the third quarter valued at about $33,000. Decker Retirement Planning Inc. acquired a new stake in Intuitive Surgical in the fourth quarter worth about $36,000. Finally, Capital Performance Advisors LLP purchased a new stake in shares of Intuitive Surgical during the third quarter worth about $38,000. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Insider Activity

In related news, EVP Robert Desantis sold 376 shares of the stock in a transaction on Friday, November 29th. The stock was sold at an average price of $539.00, for a total value of $202,664.00. Following the completion of the transaction, the executive vice president now directly owns 5,506 shares of the company’s stock, valued at approximately $2,967,734. This represents a 6.39 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CFO Jamie Samath sold 108 shares of the business’s stock in a transaction dated Tuesday, November 26th. The stock was sold at an average price of $542.06, for a total transaction of $58,542.48. Following the transaction, the chief financial officer now owns 8,757 shares in the company, valued at $4,746,819.42. The trade was a 1.22 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 5,940 shares of company stock worth $3,333,485 in the last quarter. Corporate insiders own 0.90% of the company’s stock.

Intuitive Surgical Stock Down 0.9 %

Shares of Intuitive Surgical stock opened at $582.98 on Friday. The firm has a market cap of $207.65 billion, a PE ratio of 90.95, a P/E/G ratio of 5.51 and a beta of 1.39. Intuitive Surgical, Inc. has a twelve month low of $364.17 and a twelve month high of $616.00. The business has a 50-day moving average price of $554.03 and a 200 day moving average price of $513.12.

Wall Street Analysts Forecast Growth

A number of research firms recently commented on ISRG. Leerink Partners lifted their target price on shares of Intuitive Surgical from $490.00 to $548.00 in a research note on Monday, January 27th. Royal Bank of Canada boosted their price objective on shares of Intuitive Surgical from $611.00 to $641.00 in a report on Monday, January 27th. Wells Fargo & Company raised their target price on Intuitive Surgical from $630.00 to $687.00 and gave the stock an “overweight” rating in a research note on Friday, January 24th. Erste Group Bank upgraded Intuitive Surgical from a “hold” rating to a “buy” rating in a research note on Tuesday, November 19th. Finally, Truist Financial raised their price objective on Intuitive Surgical from $640.00 to $666.00 and gave the stock a “buy” rating in a research note on Friday, January 24th. One analyst has rated the stock with a sell rating, five have given a hold rating and sixteen have assigned a buy rating to the company. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $613.10.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.